FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

23961011000001108: Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    77756501000001111 Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    77756601000001110 Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Is a Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has active ingredient Salbutamol false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has active ingredient Ipratropium bromide false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has specific active ingredient Salbutamol sulfate false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has specific active ingredient Ipratropium bromide false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Has basis of strength substance Salbutamol false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) 60 unit dose Has AMP False Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Niche Pharma Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start